NOTE F – INCOME TAXES

The Company files its income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. Federal income tax returns filed for the fiscal years ended March 31, 2024, 2023, and 2022 are considered open and subject to examination by tax authorities. Deferred income tax assets and liabilities are computed and recognized for those differences that have future tax consequences and will result in net taxable or deductible amounts in future periods. Deferred tax expense or benefit is the result of changes in the net asset or liability for deferred taxes. The deferred tax liabilities and assets for the Company result primarily from net operating loss and tax credit carry forwards, reserves, and accrued liabilities.

At March 31, 2025, the Company has total net federal operating loss carry-forwards of approximately $3,683,000 that has no fixed expiration date. In addition, the Company has research and development tax credit carry-forwards of approximately $35,000 that begin to expire in the fiscal year ending 2030. There are certain limitations to the use and application of these items. Management reviews net operating loss carry-forwards and income tax credit carry-forwards to evaluate if those amounts are recoverable. The Company expects to utilize $1,765,000 of the operating loss carry-forwards to offset the expected taxable income on the sale of a portion of the Company’s business with the filing of its tax returns for the fiscal year ending March 31, 2026. Accordingly, $361,000 of the allowance for deferred tax assets was reversed for the fiscal year ended March 31, 2025.

In addition, after a review of projected taxable income, remaining components of the deferred tax asset, and current global economic conditions, it was determined that it is more likely than not, that the tax benefits associated with the remaining components of deferred tax assets after the sale of a portion of the business, will not be realized. This determination was made based on the Company’s prior history of losses from operations and the uncertainty as to whether the Company will generate sufficient taxable income to use the remaining deferred tax assets prior to their expiration. Accordingly, a valuation allowance was established to fully offset the value of the remaining deferred tax assets. Our ability to realize the tax benefits associated with the remaining deferred tax assets depends primarily upon the timing of future taxable income and the expiration dates of the components of the deferred tax assets. If sufficient future taxable income is generated, we may be able to offset a portion of future tax expenses.

The reconciliation between the statutory federal income tax provision and the actual effective tax provision is as follows:

Years ended March 31,

    

2025

    

2024

Federal tax (benefit) at statutory rate (20.0%) before loss carry-forward

$

100,137

$

(83,116)

Permanent and other differences

 

(169,522)

 

65,581

State income tax benefit – net of federal effect

 

(19,764)

 

(18,761)

Change in deferred tax asset valuation allowance

 

(271,851)

 

36,296

Current income tax benefit

$

(361,000)

$

The individual components of the Company’s deferred tax assets are as follows:

March 31, 

    

2025

    

2024

Deferred tax assets:

Accruals and allowances

$

219,674

$

103,554

Non-deductible capitalized inventory

 

11,462

 

11,900

Net operating loss carry forward

 

736,679

 

1,124,212

Research and development tax credit carry forward

 

36,253

 

36,253

Allowance for unrealizable deferred tax assets

 

(643,068)

 

(1,275,919)

Net deferred tax asset

$

361,000

$

Historical Timeline

Fiscal YearFiled
2025Jul 29, 2025Showing above
2024Jul 12, 2024
2023Jul 14, 2023
2022Jul 14, 2022
2020Aug 11, 2020
2019Jul 15, 2019
2018Jul 16, 2018
2017Jul 14, 2017
2016Sep 28, 2016

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.